lobbying_activities: 988086
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 988086 | 8b83a362-f74d-44f8-97b7-4456a3cf9466 | Q3 | INVARIANT LLC | 314237 | HEARST CORPORATION | 2010 | third_quarter | HCR | Monitor issues related to electronic FDA drug information; discuss issues related to a universal drug pricing standard for reimbursement. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2010-10-06T11:17:27.237000-04:00 |